VAM
DVAX

Visium Asset Management’s Dynavax Technologies DVAX Stock Holding History

Visium Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,370
Closed -$28K – 895
2013
Q3 		$28K Buy
+2,370
New +$29.8K ﹤0.01% 746

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Visium Asset Management's DVAX Position: Q4 2013 in Review

Visium Asset Management sold out of Dynavax Technologies (DVAX) in Q4 2013, closing a stake of 2,370 shares — an estimated $28K sold.

Visium Asset Management first reported a position in DVAX in Q3 2013 and held it in 1 quarter. The position peaked at $28K in Q3 2013. 117 funds tracked by Wall St. Rank hold DVAX as of Q4 2013.

  • Visium Asset Management reported no remaining Dynavax Technologies position as of Q4 2013 after selling out during the quarter.
  • Visium Asset Management sold 2,370 Dynavax Technologies shares in Q4 2013, an estimated $28K.
  • Visium Asset Management first reported a position in Dynavax Technologies in Q3 2013 and held it in 1 quarter.
  • Visium Asset Management's Dynavax Technologies position peaked at $28K in Q3 2013.
  • 117 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2013.

Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.